
Several Israeli soldiers were injured in calshes in the south of the Gaza Strip, despite a fragile ceasefire, the Israeli army said on Wednesday.
The Israel Defense Forces (IDF) said "troops encountered several terrorists who emerged from an underground terrorist infrastructure." One soldier was seriously wounded.
The IDF gave no further details about the incident, which reportedly occurred in the Israeli-controlled eastern part of Rafah.
Israeli media reported that dozens of armed fighters from the Palestinian Hamas militia are holed up in tunnels in the area.
Negotiations over their demand for safe passage to areas outside Israeli military control have been rejected.
Residents told dpa on Wednesday evening that they heard loud explosions and gunfire from the area, while Hamas-aligned media in Gaza warned of possible Israeli strikes.
Since the ceasefire began on October 10, there have been repeated deadly incidents in the Gaza Strip, including fatalities among Israeli soldiers. The truce has already come under strain several times.
latest_posts
- 1
Rick Steves' Newest Guidebook Is A Fresh Perspective On Italy Spilling The Country's Secrets - 2
Figure out How to Really focus on Your Dental Inserts for Durable Outcomes - 3
Hubble sees spiral galaxy in Lion's heart | Space photo of the day for Nov. 4 - 4
Poland identifies two Ukrainian suspects in railway sabotage blast - 5
California officials warn against foraging wild mushrooms after deadly poisoning outbreak
Dear Santa: I want Botox. Why cosmetic procedures are topping holiday wish lists.
Nations for Youngsters to Visit
An Investigate of 6 Creative Specialty Mixed drinks
Different Film Classification: What's Your Go-To for Amusement
Russia Creates New Military Branch Dedicated To Drone Warfare
Strength training is crucial after menopause. How to make the most of your workouts
Changing Negative Cash Mentalities: Enabling Your Monetary Excursion
A24's 'Backrooms' trailer shows endless fluorescent-lit spaces and terrifying mannequins melting into the floor
Merck sees over $5 billion opportunity in Cidara's experimental flu drug













